Autopsy report · NCT04233489

Clinical Interventions to Mitigate Neurodevelopmental Risk

“The COVID-19 pandemic lead to halted protocols containing human subjects and in person interactions”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Columbia University

Sponsor type

University, hospital or other

Conditions

Child Development; Mother-Infant Interaction; Diabetes Mellitus, Gestational

Interventions

Family Nurture Intervention (FNI)

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Piloting Conversation Cards for Adolescents
  “Ongoing COVID-19 restrictions and very low (in-person) clinical activity prevented participant recruitment.” (68% match in meaning)
• Tobacco Cessation for Sexual Minorities
  “Covid-19 quarantines and closures prevented recruitment and assessment of participants.” (66% match in meaning)
• Effects of Exercise and Yogurt on Bone Mineral Density and Immunological Factors in Human Milk: The MEEMA Study
  “COVID 19 pandemic” (65% match in meaning)
• Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65
  “COVID-19 prevented us from doing this human subjects study” (65% match in meaning)
• High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Bulimia and Anorexia Nervosa
  “COVID-19 pandemic restrictions.” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.